Spiber Technologies uses recombinant technology for producing advanced biomaterials. Our primary goal is to develop and commercialize state-of-the-art patented technologies based on the recombinant spider silk protein Spiber™ and the solubility tag SolvNT™ Spiber™-based products can be used as 3D scaffold for culturing stem cells and creating future Regenerative Medicine applications. SolvNT™ can increase solubility for recombinant production of peptides and proteins. The company was founded in 2008. The technologies are based on the successful research on spider silk conducted at the Swedish University of Agricultural Sciences (SLU), the Royal Institute of Technology (KTH) and Karolinska Institutet (KI). The company is privately owned and located in Stockholm, Sweden.